Literature DB >> 7975229

Substitution mutations affecting a small region of the Moloney murine leukemia virus MA gag protein block assembly and release of virion particles.

C Granowitz1, S P Goff.   

Abstract

A series of substitution mutations affecting the Moloney murine leukemia virus MA protein were introduced into a cloned proviral DNA, and the mutant DNAs were tested for their biological activity in NIH/3T3 cells and COS cells. Many of the mutant viruses were viable and replicated with kinetics indistinguishable from the wild type. Seven mutants with alterations in a small region (residues 7-14 from the amino terminus) were replication-defective. These mutants were blocked in assembly and release of the virion particles in NIH/3T3 cells and were defective in both gag and gag-pol gene function. The results suggest that this very small region near the amino terminus of both proteins is required for their membrane targeting or self-association. Three of the defective mutant DNAs were able to induce virion particle formation when present at high copy number in COS cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975229     DOI: 10.1006/viro.1994.1650

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport.

Authors:  Y Soneoka; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures.

Authors:  G Schumann; L Qin; A Rein; G Natsoulis; J D Boeke
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  N-terminal Gag domain required for foamy virus particle assembly and export.

Authors:  Marc Cartellieri; Ottmar Herchenröder; Wolfram Rudolph; Martin Heinkelein; Dirk Lindemann; Hanswalter Zentgraf; Axel Rethwilm
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein.

Authors:  Margaret Q Wang; Stephen P Goff
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly.

Authors:  E Bacharach; J Gonsky; K Alin; M Orlova; S P Goff
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.

Authors:  Amanda K Dalton; Paul S Murray; Diana Murray; Volker M Vogt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Basic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse.

Authors:  Fei Li; Jing Jin; Christin Herrmann; Walther Mothes
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Murine leukemia virus Gag localizes to the uropod of migrating primary lymphocytes.

Authors:  Fei Li; Xaver Sewald; Jing Jin; Nathan M Sherer; Walther Mothes
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.

Authors:  E Hamard-Peron; F Juillard; J S Saad; C Roy; P Roingeard; M F Summers; J-L Darlix; C Picart; D Muriaux
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.